Recent advances in targeted nanoparticles drug delivery to melanoma

Due to its high multidrug resistance and low survival rate, melanoma is one of the most aggressive skin cancers. Fortunately, the applications of nanocarriers are widely expected to change the landscape of melanoma therapy for foreseeable future. We will demonstrate recent development in the application of multifunctional nanoparticles for targeted drug delivery (active and passive targeting) to melanoma, in melanoma nanotheranostics and combination therapy, and nanopharmaceutical associated melanoma clinical trials. Moreover, we will discuss current status, challenges, and perspectives of the targeted NPs drug delivery to melanoma.217